- Home
- FDMT vs CYRX Comparison
FDMT vs CYRX Comparison
Compare FDMT & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FDMT | CYRX |
|---|---|---|
| Founded | 2013 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 455.4M | 472.7M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | FDMT | CYRX |
|---|---|---|
| Price | $7.21 | $10.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 9 |
| Target Price | ★ $30.33 | $12.83 |
| AVG Volume (30 Days) | ★ 1.2M | 448.0K |
| Earning Date | 11-10-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.27 |
| Revenue | $120,000.00 | ★ $243,795,000.00 |
| Revenue This Year | $21,181.08 | N/A |
| Revenue Next Year | $162.43 | $9.26 |
| P/E Ratio | ★ N/A | $7.77 |
| Revenue Growth | ★ 605.88 | 41.27 |
| 52 Week Low | $2.24 | $4.58 |
| 52 Week High | $12.34 | $11.44 |
Technical Indicators
Market Signals| Indicator | FDMT | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 29.73 | 61.81 |
| Support Level | $6.96 | $9.44 |
| Resistance Level | $11.81 | $9.87 |
| Average True Range (ATR) | 0.68 | 0.33 |
| MACD | -0.18 | 0.03 |
| Stochastic Oscillator | 4.95 | 85.96 |
Price Performance
Historical ComparisonAbout FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.